Literature DB >> 7958027

Conduction properties of central demyelinated and remyelinated axons, and their relation to symptom production in demyelinating disorders.

K J Smith1.   

Abstract

The conduction properties of central demyelinated and remyelinated axons are discussed, and related to the expression of symptoms in central demyelinating disease. The mechanisms underlying the block and restoration of conduction in segmentally demyelinated axons are described, together with the range of deficits expressed by the conducting axons. These abnormalities are related to clinical relapses and remissions, and to the phenomena of weakness, fatigue, the temperature sensitivity of symptoms, and the generation of 'positive' symptoms (e.g. Uhthoff's and Lhermitte's symptoms). The potential role of circulating 'blocking factors' in the symptomatology of central demyelinating disease is examined, and some approaches are advanced for the symptomatic therapy of such diseases.

Entities:  

Mesh:

Year:  1994        PMID: 7958027     DOI: 10.1038/eye.1994.51

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  15 in total

Review 1.  Uhthoff's phenomena in MS--clinical features and pathophysiology.

Authors:  Teresa C Frohman; Scott L Davis; Shin Beh; Benjamin M Greenberg; Gina Remington; Elliot M Frohman
Journal:  Nat Rev Neurol       Date:  2013-06-04       Impact factor: 42.937

2.  Histochemical localisation of mitochondrial enzyme activity in human optic nerve and retina.

Authors:  R M Andrews; P G Griffiths; M A Johnson; D M Turnbull
Journal:  Br J Ophthalmol       Date:  1999-02       Impact factor: 4.638

3.  Impaired sweating responses to a passive whole body heat stress in individuals with multiple sclerosis.

Authors:  Dustin R Allen; Mu Huang; Iqra M Parupia; Ariana R Dubelko; Elliot M Frohman; Scott L Davis
Journal:  J Neurophysiol       Date:  2017-03-08       Impact factor: 2.714

4.  Quantification of central motor conduction deficits in multiple sclerosis patients before and after treatment of acute exacerbation by methylprednisolone.

Authors:  A M Humm; W J Z'Graggen; R Bühler; M R Magistris; K M Rösler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09-20       Impact factor: 10.154

5.  Slow-gamma frequencies are optimally guarded against effects of neurodegenerative diseases and traumatic brain injuries.

Authors:  Pedro D Maia; Ashish Raj; J Nathan Kutz
Journal:  J Comput Neurosci       Date:  2019-06-04       Impact factor: 1.621

Review 6.  The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease.

Authors:  K J Smith; W I McDonald
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

Review 7.  Human temperature regulation under heat stress in health, disease, and injury.

Authors:  Matthew N Cramer; Daniel Gagnon; Orlando Laitano; Craig G Crandall
Journal:  Physiol Rev       Date:  2022-06-09       Impact factor: 46.500

Review 8.  Neuroprotection by central nervous system remyelination: Molecular, cellular, and functional considerations.

Authors:  Dylan Verden; Wendy B Macklin
Journal:  J Neurosci Res       Date:  2016-09-12       Impact factor: 4.433

Review 9.  A new role for evoked potentials in MS? Repurposing evoked potentials as biomarkers for clinical trials in MS.

Authors:  Martin Hardmeier; Letizia Leocani; Peter Fuhr
Journal:  Mult Scler       Date:  2017-05-08       Impact factor: 6.312

Review 10.  Sodium channels and multiple sclerosis: roles in symptom production, damage and therapy.

Authors:  Kenneth J Smith
Journal:  Brain Pathol       Date:  2007-04       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.